Clinical trial

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

NCT00021749

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-01-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2001-01-01Date precision: month

Registry last updated2009-11-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Lymphocytic Leukemiaunresolved

CLLunresolved

Interventions

Oblimerson sodium, G3139DRUG

Sponsors & collaborators

Genta Incorporatedlead sponsor

Mapped research locations

HoustonTexas, United States1 San AntonioTexas, United States1 New Hyde ParkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00021749 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.